Learn / CABA
NASDAQ: CABA
Cabaletta Bio (CABA) stock, explained like you're 5
Cabaletta Bio trades on the Nasdaq under the ticker CABA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 327 million dollars.
- Ticker
- CABA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 327 million dollars
Is Cabaletta Bio a small, medium or large cap company?
No. Cabaletta Bio is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 327 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Cabaletta Bio makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CABA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- CABA Stock Price and Chart NASDAQ:CABA (TradingView)
- CABA Stock Slips As Traders Weigh Cash Runway And Losses (Timothy Sykes)
- Cabaletta Bio Slides As Insider Purchases Lose Another US$60k (Webull)
- Cabaletta Bio: 40% Sell Off Creates An Opportunity Despite Cash Concerns (Seeking Alpha)
- CABA 260918 5.50C (CABA260918C5500) Stock Options Chain | Quotes & News (Moomoo)
Follow CABA in your daily brief
Each trading day at 5 PM ET we post what happened to Cabaletta Bio and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CABA
Questions about Cabaletta Bio stock
What does Cabaletta Bio do?
Cabaletta Bio trades on the Nasdaq under the ticker CABA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 327 million dollars.
What is the ticker symbol for Cabaletta Bio?
Cabaletta Bio trades under the ticker CABA on the Nasdaq.
What is Cabaletta Bio's market cap?
Cabaletta Bio is a small cap stock with a market cap of about 327 million dollars.
How does Cabaletta Bio make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CABA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CABA stock every day?
Add CABA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.